Today’s Frontline SOC in Multiple Myeloma

 

Insights from 2023 ASH Annual Meeting
P

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorporating Data From ASH"

By Insights from 2023 ASH Annual Meeting FEATURING Paul Richardson
By Insights from 2023 ASH Annual Meeting FEATURING Paul Richardson
697 views
January 18, 2024
0 Comments
Login to view comments. Click here to Login
Today’s Frontline SOC in Multiple Myeloma
11:02
Winship Cancer Institute - Emory University

Multiple Myeloma: Clinical Challenges for the Community Clinician

Feat. N. Joseph
05:47
Meletios Dimopoulos

PERSEUS Study Primary Results: Daratumumab + VRd vs. VRd Alone in Pa…

30:18
UChicago Medicine

Practice-Changing and Promising New Treatments in Myeloma

Feat. B. Derman
04:59
ecancer

PERSEUS Trial Summary: Adding Daratumumab to VRd as a Frontline Ther…

Feat. P. Sonneveld
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
19:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…

Feat. P. Richardson
08:36
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligi…

Feat. N. Joseph